CordenPharma, the global pharmaceutical service and manufacturing platform of International Chemical Investors Group, completed the acquisition of three manufacturing facilities from Vifor Pharma, a global specialty pharmaceuticals company. Financial terms were not disclosed. "We welcome the three sites and their employees as new members to the CordenPharma Group and look forward to working with Vifor in the future to supply Vifor Pharma's finished drug products, including to their already existing customers. The acquired pharma sites have a well-trained workforce with great cultural fit, state-of-the art infrastructure, and a strong compliance track record. This excellent opportunity aligns well with our strategy to broaden our CDMO capabilities," Michael Quirmbach, CordenPharma President and CEO.